ImmueMed
Contact Us
KO
Company
Company Introduction
CEO Greeting
Organizational Status
Mission & Business Strategy
Direction
R & D
Antiviral Agent
Research Projects
Pipeline
Company News
Publicity
Investment Information
Notice
Financial Information
Investment Inquiry
Company
Company Introduction
CEO Greeting
Organizational Status
Mission & Business Strategy
Direction
R & D
Antiviral Agent
Research Projects
Pipeline
Company News
Publicity
Investment Information
Notice
Financial Information
Investment Inquiry
Overall Menu
Company
Company
Introduction
CEO Greeting
Organizational Status
Mission & Business Strategy
Direction
R & D
Antiviral Agent
Research Projects
Pipeline
Company News
Publicity
Investment Information
Investment
Information
Notice
Financial Information
Investment Inquiry
Press Release | ImmuneMed
Press Release
Home
Company News
Company
R & D
Company News
Investment Information
Publicity
Publicity
Press Release
Video Clip
[Press Release] ImmuneMed’s ‘hzVSF,’ A New Hope for COVID-19 Pneumonia Patients
Writer
|
ImmuneMed
Views
|
2496
Date
|
2020-04-01
Prev 및 Next
Prev
COVID-19 Phase 2 Clinical Study Approval (Russia), October 15th, 2020
2020-11-10
Next
[BiopharmaDealmakers] ImmuneMed : lifting the burden of infectious disease
2020-02-18